114 related articles for article (PubMed ID: 12543197)
1. Immunohistochemical study of epiretinal proliferative cellular tissue from a patient with sarcoidosis.
Fukushima A; Hashida M; Hayashi N; Hiroi M; Ueno H
Jpn J Ophthalmol; 2002; 46(6):675-8. PubMed ID: 12543197
[TBL] [Abstract][Full Text] [Related]
2. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis.
Kojima K; Maruyama K; Inaba T; Nagata K; Yasuhara T; Yoneda K; Sugita S; Mochizuki M; Kinoshita S
Ophthalmology; 2012 Nov; 119(11):2386-92. PubMed ID: 22809758
[TBL] [Abstract][Full Text] [Related]
3. Histopathological findings in proliferative membrane from a patient with sarcoid uveitis.
Miyao A; Ikeda T; Matsumoto Y; Uchida K; Machida T; Hongo M; Kinoshita S
Jpn J Ophthalmol; 1999; 43(3):209-12. PubMed ID: 10413255
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study.
Maruyama K; Inaba T; Sugita S; Ichinohasama R; Nagata K; Kinoshita S; Mochizuki M; Nakazawa T
BMJ Open; 2017 Nov; 7(11):e014549. PubMed ID: 29150462
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green-assisted peeling of the epiretinal membrane in proliferative vitreoretinopathy.
Sakamoto H; Yamanaka I; Kubota T; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):204-7. PubMed ID: 12644944
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study.
Ueno A; Enaida H; Hata Y; Hisatomi T; Nakamura T; Mochizuki Y; Sakamoto T; Ishibashi T
Eur J Ophthalmol; 2007; 17(3):392-8. PubMed ID: 17534822
[TBL] [Abstract][Full Text] [Related]
9. [Epiretinal membranes: reasons not to perform vitreoretinal surgery].
Bonnel S; Barale PO; Laroche L; Sahel JA; Monin C
J Fr Ophtalmol; 2008 Feb; 31(2):200-7. PubMed ID: 18401323
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of intraocular lesions using vitreous humor and intraocular perfusion fluid cytology: Experience with 83 Cases.
Kinoshita Y; Takasu K; Kobayashi TK; Yuri T; Tsubura A; Shikata N
Diagn Cytopathol; 2015 May; 43(5):353-9. PubMed ID: 25334001
[TBL] [Abstract][Full Text] [Related]
11.
Goto H; Usui Y; Umazume A; Uchida K; Eishi Y
Br J Ophthalmol; 2017 Nov; 101(11):1510-1513. PubMed ID: 28270483
[TBL] [Abstract][Full Text] [Related]
12. Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis.
Maruyama K; Inaba T; Tamada T; Nakazawa T
Medicine (Baltimore); 2016 Dec; 95(49):e5531. PubMed ID: 27930546
[TBL] [Abstract][Full Text] [Related]
13. [The significance of fibroblasts in experimental modeling of proliferative vitreoretinopathy].
Khoroshilova-Maslova IP; Leparskaya NL; Vorotelyak EA; Vasiliev AV
Vestn Oftalmol; 2017; 133(5):4-10. PubMed ID: 29165406
[TBL] [Abstract][Full Text] [Related]
14. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
15. [A case of proliferative sarcoid retinopathy with sarcoid nodules in tissue obtained during vitrectomy].
Ogawa A; Sato Y; Miyasaka S; Fujita K; Shimada H; Kinukawa N
Nippon Ganka Gakkai Zasshi; 2000 Mar; 104(3):174-8. PubMed ID: 10752341
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
Cao J; Wu L; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
[TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.
Sonoda KH; Enaida H; Ueno A; Nakamura T; Kawano YI; Kubota T; Sakamoto T; Ishibashi T
Br J Ophthalmol; 2003 Aug; 87(8):1010-4. PubMed ID: 12881346
[TBL] [Abstract][Full Text] [Related]
19. Bronchoalveolar lavage studies in uveitis patients without radiological intrathoracic involvement of sarcoidosis.
Sugimoto M; Nakashima H; Ando M; Kohrogi H; Araki S
Jpn J Med; 1989; 28(1):50-4. PubMed ID: 2524616
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.
Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ
Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
